(Q93528899)

English

Estrogenic action of tamoxifen in women treated with luteinizing hormone-releasing hormone agonists (goserelin)--lack of shrinkage of uterine fibroids

No description defined

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2531684%20AND%20SRC:MED&resulttype=core&format=json

7 May 2020

Estrogenic action of tamoxifen in women treated with luteinizing hormone-releasing hormone agonists (goserelin)--lack of shrinkage of uterine fibroids (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2531684%20AND%20SRC:MED&resulttype=core&format=json

7 May 2020

1 reference

based on heuristic

inferred from title

uterine fibroid

1 reference

based on heuristic

inferred from title

author name string

M A Lumsden

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2531684%20AND%20SRC:MED&resulttype=core&format=json

7 May 2020

C P West

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2531684%20AND%20SRC:MED&resulttype=core&format=json

7 May 2020

H Hillier

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2531684%20AND%20SRC:MED&resulttype=core&format=json

7 May 2020

D T Baird

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2531684%20AND%20SRC:MED&resulttype=core&format=json

7 May 2020

publication date

1 December 1989

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2531684%20AND%20SRC:MED&resulttype=core&format=json

7 May 2020

Fertility and Sterility

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2531684%20AND%20SRC:MED&resulttype=core&format=json

7 May 2020

52

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2531684%20AND%20SRC:MED&resulttype=core&format=json

7 May 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2531684%20AND%20SRC:MED&resulttype=core&format=json

7 May 2020

924-929

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2531684%20AND%20SRC:MED&resulttype=core&format=json

7 May 2020

The binding of steroids to myometrium and leiomyomata (fibroids) in women treated with the gonadotrophin-releasing hormone agonist Zoladex (ICI 118630)

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953153-7

7 January 2021

A conservative approach to the management of uterine leiomyoma: pituitary desensitization by a luteinizing hormone-releasing hormone analogue

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953153-7

7 January 2021

Shrinkage of uterine fibroids during therapy with goserelin (Zoladex): a luteinizing hormone-releasing hormone agonist administered as a monthly subcutaneous depot

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953153-7

7 January 2021

Treatment of leiomyomata with intranasal or subcutaneous leuprolide, a gonadotropin-releasing hormone agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953153-7

7 January 2021

Treatment of leiomyomata uteri with D-Trp6-luteinizing hormone-releasing hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953153-7

7 January 2021

Tamoxifen prolongs luteal phase in premenopausal women but has no effect on the size of uterine fibroids

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953153-7

7 January 2021

Toward removing uterine fibroids without surgery: subcutaneous infusion of a luteinizing hormone-releasing hormone agonist commencing in the luteal phase

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953153-7

7 January 2021

Reduction of non-specific serum responses in human pituitary gonadotrophin radioimmunoassays

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953153-7

7 January 2021

Comparison of single and repeated applications of a long-acting synthetic analogue of LHRH [D-Ser (TBU)6 EA10 LHRH] in the assessment of pituitary gonadotrophin secretory capacity

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953153-7

7 January 2021

Pulsatile secretion of LH, FSH, prolactin, oestradiol and progesterone during the human menstrual cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953153-7

7 January 2021

Hypothalamic-pituitary-ovarian function in perimenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953153-7

7 January 2021

Transplacental gradients of sex-hormone-binding globulin in human and simian pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953153-7

7 January 2021

Anti-tumor and endocrine effects of chronic LHRH agonist treatment (Buserelin) with or without tamoxifen in premenopausal metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953153-7

7 January 2021

Suppression of ovarian activity by Zoladex depot (ICI 118630), a long-acting luteinizing hormone releasing hormone agonist analogue

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953153-7

7 January 2021

Sustained gonadal suppression in fertile women with the LHRH agonist buserelin

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953153-7

7 January 2021

Treatment of menometrorrhagia with an anti-oestrogen

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953153-7

7 January 2021

The pharmacology and clinical uses of tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953153-7

7 January 2021

Tamoxifen inhibits osteoclast-mediated resorption of trabecular bone in ovarian hormone-deficient rats

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953153-7

7 January 2021

Tamoxifen as risk factor for carcinoma of corpus uteri

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953153-7

7 January 2021

Identifiers

10.1016/S0015-0282(16)53153-7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2531684%20AND%20SRC:MED&resulttype=core&format=json

7 May 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2531684%20AND%20SRC:MED&resulttype=core&format=json

7 May 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q93528899&oldid=2090980090"